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Breast milk is unique as a matrix for bio-
monitoring because, in addition to serving as
a matrix for the many uses of biomonitoring,
it also serves as a food source for a segment
of the human population; thus, the analyses
of breast milk for environmental chemicals
as well as for nutrients are of wide scientiﬁc
interest. One of the earliest reports of the
measurement of an environmental chemical
in breast milk was by Laug et al. in 1951 (1).
They reported that the breast milk from 32
women from the general population of
Washington, DC, contained 1,1,1-trichloro-
2, 2-bis(4-chlorophenyl)ethane (p,p´-DDT
or DDT) at an average concentration of
0.13 ppm. Laug et al. (1) attributed the pri-
mary source of DDT to their diet. Over the
years, many more chemicals have been mea-
sured in human breast milk, our under-
standing of the interaction between
lactation and exposure to environmental
chemicals has grown, and our analytic
methods have become more sophisticated.
Because the fat content of milk is relatively
high, most of the chemicals that have been
monitored in milk are those that have high
lipid solubility, in particular, polyhalo-
genated chemicals. These chemicals tend to
degrade slowly in the environment, to
bioaccumulate and bioconcentrate in the
food chain, and to have long half-lives in
humans. Certain adverse health and repro-
ductive outcomes have been attributed to
these chemicals in laboratory animals and
in wildlife, as well as in humans. Therefore,
public health officials, environmental regu-
lators, and scientists are concerned about
their sources, their presence in our ecosys-
tems and in people, and ﬁnally the relation
between exposure and adverse health out-
comes. Scientists develop and apply meth-
ods to measure these chemicals in human
specimens, such as breast milk, and also in
other matrices, both environmental and
biological. These methods present chal-
lenges, such as the need for overcoming the
relatively high fat content of milk while
still maintaining all of the characteristics of
state-of-the-art analytic methods. In this
paper we note those characteristics and
means of ensuring that they are met; we
also describe in summary how breast milk
is made, how environmental chemicals are
incorporated into the milk, and factors
that influence the levels of these chemicals
in milk.
Incorporation of Environmental
Chemicals into Breast Milk
Following human exposure, environmental
chemicals can be absorbed into the blood-
stream by three routes: ingestion, inhalation,
and dermal contact. These chemicals circulate
in the bloodstream, either bound to carrier
proteins such as albumin and lipoproteins or
in their free form, and distribute among tissue
compartments throughout the body (2).
Initially, the rate of distribution of chemicals
within the body is a function of tissue perfu-
sion, which is the rate of blood ﬂow through
the various tissues. Highly vascular organs
accumulate the chemicals first. Then, as
equilibrium states are reached, the chemicals
redistribute, and chemicals with high lipid
solubility concentrate in tissues with higher
fat content, such as adipose tissue, brain,
liver, kidney, and, in the case of lactating
women, breast milk. 
In lactating women, lactogenesis begins
about 40 hr after the birth of their offspring.
During the ﬁrst 3–5 days after delivery, the
milk is low in volume and in fat (lipid) con-
tent (2.9%) and is called “colostrum.” Over
the next 2–6 weeks, the transitional milk
matures and increases in fat content to about
4%. The lipids are important for infant brain
development; the major class of lipids in milk
is the triglycerides, which are made from
fatty acids such as arachidonic and docosa-
hexaenoic acids (3). Breast milk is made up
of several other components including carbo-
hydrates, proteins, and minerals, especially
calcium. Milk is synthesized in the mammary
alveolar gland; to synthesize milk, milk com-
ponents and their precursors pass through a
membrane that separates the blood flowing
in capillaries from the alveolar epithelial cell
of the breast. However, during this process
certain environmental chemicals present in
the blood also can pass through the mem-
brane and be incorporated into the breast
milk at concentrations comparable to the
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The presence of environmental chemicals in human breast milk is of general concern because of
the potential health consequence of these chemicals to the breast-fed infant and the mother. In
addition to the mother’s exposure, several features determine the presence of environmental
chemicals in breast milk and their ability to be determined analytically. These include maternal
factors and properties of the environmental chemical—both physical and chemical—such as its
lipid solubility, degree of ionization, and molecular weight. Environmental chemicals with high
lipid solubility are likely to be found in breast milk; they include polyhalogenated compounds
such as polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofu-
rans, organochlorine insecticides, and polybrominated diphenylethers. These fat-soluble chemi-
cals are incorporated into the milk as it is synthesized, and they must be measured in accordance
with the fat content of the milk to allow for meaningful comparisons within an individual and
among populations. Although the analytic approach selected to measure the environmental chem-
ical is predominantly determined by the characteristics of the chemical, the concentration of the
chemical in the milk sample and the existence of structurally similar chemicals (e.g., congeners)
must be considered as well. In general, the analytic approach for measuring environmental chemi-
cals in breast milk is similar to the approach for measuring the same chemicals in other matrices,
except special considerations must be given for the relatively high fat content of milk. The contin-
ued efforts of environmental scientists to measure environmental chemicals in breast milk is
important for deﬁning the true contribution of these chemicals to public health, especially to the
health of the newborn. Work is needed for identifying and quantifying additional environmental
chemicals in breast milk from the general population and for developing analytic methods that
have increased sensitivity and the ability to speciate various chemicals. Key words: analytic, chemi-
cal, environment, human breast milk, measurement, toxicant. Environ Health Perspect
110:A317–A324 (2002). [Online 13 May 2002]
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CHEMICAL CONTAMINANTS IN BREAST MILK
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in the body (4,5). The most common mech-
anism for the passage of environmental
chemicals is passive transport, which in gen-
eral allows passage of lipophilic components
of molecular weight < 800 Da; thus, lipid
solubility of a chemical is a primary factor for
its incorporation into breast milk. Factors
that affect the lipophilic character of a chemi-
cal include its chemical structure and its
degree of ionization (pKa) in the body com-
partments. For example, in general, halogens
increase the lipophilic nature of a chemical.
Also, chemicals in their nonionized state are
more lipophilic than when in their ionized
state and hence are more likely to diffuse into
breast milk when in their nonionized state.
Because the pH of plasma is 7.40, weakly
acidic chemicals tend to exist primarily in
their ionized form and thus are less likely
than weak bases to pass through the mem-
brane and into milk, which has a pH of
7.0–7.25 (6). 
However, the passive transport mecha-
nism for lipid-soluble chemicals is not the
only mechanism for chemicals to cross cell
membranes. For example, low molecular
weight (< 200 Da) water-soluble chemicals
can cross cell membranes with the bulk
transfer of water. On the other hand, chemi-
cals of high molecular weight (> 800 Da)
tend not to pass through the membrane and
likely do not enter breast milk to a measur-
able degree. Also, chemicals (e.g., heavy met-
als) that are highly bound to either plasma
proteins or erythrocytes are unlikely to pas-
sively diffuse into milk (7). Overall, the
amount of protein-bound chemical that
enters milk is of little concern because the
protein compartment in the blood is far
greater than that in breast milk. 
Other factors that affect the presence of a
chemical in breast milk are its degree of bio-
transformation and its elimination rate.
Frequently, the biotransformation processes,
Phase I and Phase II, produce a metabolite
that is more water soluble than the parent
chemical and is readily eliminated through
the kidney into the urine; hence, the chemi-
cal is not available for incorporation into
breast milk. Less frequently, the metabolite
is sustained in the blood and tissues, includ-
ing breast milk, and is more readily mea-
sured than the original chemical (e.g., aldrin
is metabolized to dieldrin and DDT is
metabolized to DDE). With regard to the
elimination rate, chemicals with a slow elim-
ination rate have a long half-life, which
allows for more time in the body and hence
more time for bioaccumulation in breast
milk. Many halogenated compounds, includ-
ing the organochlorine insecticides (e.g.,
DDT and cyclodienes), polychlorinated
biphenyls (PCBs), polybrominated biphenyls
(PBBs), polychlorinated dibenzo-p-dioxins
(PCDDs), and polychlorinated dibenzofu-
rans (PCDFs), have long biological half-lives
and are persistent in the environment and in
humans because of their resistance to oxida-
tive degradation and metabolism. The num-
ber of halogen atoms and the position of the
halogen atoms on the molecule modulate
these enzymatic processes (8). For example,
the reported biological half-life for 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) is 7.2
years, whereas the reported estimates for other
dioxins are 3.7 years for 1,2,3,4,6,7,8-hep-
tachlorodibenzo-p-dioxin and 15.7 years for
1,2,3,7,8-pentachlorodibenzo-p-dioxin (9). 
For many of these long-lived environ-
mental chemicals in lactating women, breast
milk may be a major route of their elimina-
tion (10). Lipid-soluble chemicals are trans-
ported from adipose tissue stores to the lipids
in breast milk and then eliminated from the
body during breast-feeding. Thus, during a
single lactation period or after several chil-
dren and lactation periods, the concentration
of a persistent chemical tends to decrease,
assuming only background exposures to that
chemical. This process of decreasing levels of
chemicals during the breast-feeding period is
known as “depuration” (11). For example,
the half-life of total PCBs and DDT in
human milk has been estimated to be
approximately 6 months (12). 
The Role of Breast Milk in
Biological Monitoring
Programs
In the body, lipophilic chemicals are stored
and equilibrated in tissue compartments with
high fat content (e.g., breast milk and adipose
tissue). In actuality, adipose tissue, breast
milk, and blood or its components have been
used for biological monitoring for assessing
human exposure to lipophilic chemicals.
Biological monitoring of these chemicals has
several advantages over environmental moni-
toring because the former measures the inter-
nal dose rather than the exposed dose, and
accounts for exposure from all sources (resi-
dential and work), all environmental path-
ways (through air, water, food, soil, surfaces),
and all routes of absorption (ingestion, der-
mal, inhalation). However, biological moni-
toring may or may not yield information
about speciﬁc sources, routes, and pathways
that are important for risk management pur-
poses. The most common reason for large-
scale national biomonitoring programs is to
monitor a population’s exposure to chemi-
cals, such as organochlorine insecticides,
industrial chemicals and by-products (PCBs,
PCDDs, PCDFs, lead), and solvents, and to
determine whether a population’s exposure
to these chemicals is changing over time. The
consequence of such information assists in
the determination of directed efforts in
research, regulation, and policy design to
improve public health care and safety. 
In the United States, breast milk has not
recently been used to a large degree in bio-
monitoring programs. The largest biomoni-
toring studies involving breast milk in the
United States were conducted at Colorado
State University. The ﬁrst, conducted from
1974 to 1976, comprised 1,436 nursing
women in hospitals; their milk samples were
analyzed for selected chlorinated hydrocar-
bon insecticides and later for PCBs (13).
The second national study, conducted from
1977 through 1983 by the same laboratory,
comprised a total of 1,842 milk samples,
which also were collected from women resid-
ing throughout the United States and were
analyzed for the same organochlorine insecti-
cides and PCBs (13). Also, in 1980 the U.S.
Environmental Protection Agency (EPA)
reported qualitative and semiquantitative
data on levels of volatile organic compounds
and semivolatile organic compounds in milk
samples collected from lactating women in
ﬁve U.S. cities (14). Despite these earlier ini-
tiatives, milk has not been routinely moni-
tored in recent national surveys, such as the
National Human Adipose Tissue Survey (15),
which analyzed adipose tissue, and the
National Health and Nutrition Examination
Surveys (16) and the piloted National Human
Exposure Assessment Survey (17), which both
monitored blood and urine. However, breast
milk has been more widely used in biomoni-
toring programs in Europe and Canada (18).
For example, Norén and Meironyte (19) in
Sweden and Fürst et al. (20) in Germany
reported that the milk levels of PCDDs,
PCDFs, and PCBs decreased dramatically
from the early 1970s to the late 1990s. In con-
trast, Norén and Meironyte (19) reported a
dramatic increase in milk levels of selected
polybrominated diphenylethers (PBDE) con-
geners over this period. The World Health
Organization (WHO) European Centre for
Environment and Health is conducting its
third ﬁeld study, which is designed to assess
levels and changes in levels of PCDDs,
PCDFs, and selected PCBs in breast milk in
countries worldwide (21). 
Breast milk is a convenient specimen for
biomonitoring programs because relatively
large volumes (50–100 mL) can be collected
noninvasively. This makes it a suitable
matrix to be sampled in a large and easily
identiﬁed population, albeit a selected popu-
lation of women of reproductive age who are
lactating. Because only this specific sample
demography can be used, the use of mother’s
milk in a probability-based survey, the
results of which are intended to be extracted
to the general population, is questionable.
Nevertheless, exposure in this segment of the
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tor, and milk is important to monitor for
contaminants because breast milk is a
human food and is the major route of expo-
sure to these contaminants by the breast-
feeding newborn. 
Another reason to monitor breast milk is
that it reflects the maternal total body bur-
den for lipophilic chemicals. Furthermore,
concentrations of lipophilic chemicals in
breast milk indicate the levels of these chem-
icals in the mother’s fat stores during preg-
nancy and, consequently, provide a
dosimeter of prenatal exposure to these
chemicals. If used for this purpose, the milk
should be collected in a narrow window of
time as soon postpartum as possible to
reduce the effects of depuration. However,
any fat-containing matrix could be sampled
from the mother and used for this dosimeter
because lipophilic compounds partition
within the body primarily on the basis of the
fat content of the tissue. The average fat
content of mature breast milk is about 4%.
In contrast, serum contains 0.5–0.6% lipids
and adipose tissue may range in lipids from
65% to > 90%, depending on the location
in the body from where it is taken and the
method used for procuring it (e.g., surgical,
needle biopsy, or liposuction). The lipid-par-
titioning effect was demonstrated in a study
of a population exposed to varying levels of
TCDD (22). Patterson et al. (22) reported
that, on average, levels of TCDD were 158
times higher in adipose tissue than in serum,
but when each matrix was adjusted for its
lipid content, the levels of TCDD were
comparable in each matrix. Thus, tissue per-
fusion and the lipid partition coefﬁcient [or
bioconcentration factor (23)] play important
roles in the distribution of chemicals in the
body. In the case of PBBs, their concentra-
tions in breast milk were reported to be
0.7–0.9 times that of adipose tissue when
results from both were reported on a lipid-
adjusted basis; in the same study the lipid-
adjusted adipose tissue and breast milk
concentrations were 107–119 times that of
plasma, when results from the latter matrix
were reported on a whole weight basis (24). 
However, the level of fat and the level of
environmental chemicals in breast milk
require consideration of several factors
beyond the degree and duration of exposure,
the effects of depuration, and the time of
sampling during lactation. These include
characteristics of the mother. Maternal fea-
tures that affect these levels include the health
of the mother during pregnancy and during
the lactation period, presence and levels of
other xenobiotics (including environmental
chemicals and pharmaceutical agents) that
may alter metabolism, change in body mass
index during pregnancy and lactation, diet,
other factors that may mobilize fat, parity and
length of previous lactation, number of chil-
dren being breast-fed at one time, maternal
age, and maternal body mass index. Also of
importance is the variation of the fat content
during lactogenesis and during the course of
feeding (25–27). We have already mentioned
that the fat content during lactogenesis tends
to increase from about 2.9% during the ﬁrst
few days and then stabilizes at around 4%
after 2–6 weeks. During the actual time of
breast-feeding, the foremilk can have a fat
content of about 1% and the hindmilk can
have a fat content of up to 12%; levels of fat
can also differ between the two breasts. Also,
if an infant empties the milk content of one
breast, the foremilk from the second breast is
generally higher in fat content than the
foremilk was from the ﬁrst breast. For moni-
toring surveys, breast milk should be collected
once the fat content has stabilized; the proto-
col of WHO-Europe calls for sampling 2
weeks to 2 months after delivery (21); how-
ever, more studies need to be conducted to
determine whether the milk is comparable
during this 8-week period. 
The Role of Breast Milk
Monitoring in Epidemiologic
Studies
In addition to monitoring breast milk purely
for exposure assessment purposes, researchers
have analyzed breast milk to determine the
relation between concentrations of environ-
mental chemicals and adverse effects in
humans; thus, the determination of potential
health consequences of contaminated breast
milk to the infants and their mothers is
another important reason to conduct biolog-
ical monitoring in breast milk. Several inci-
dents have been reported of women being
exposed to chemicals, then breast-feeding
their children with contaminated milk, and
the children having adverse effects, espe-
cially neurodevelopmental effects. These
reported chemicals include PCBs (28–31),
PCBs/PCDDs/PCDFs (32–34), PBBs (35),
hexachlorobenzene (36), methylmercury
(37,38), and DDT (25). Although transpla-
cental exposure is generally believed to be
more consequential to the health outcomes
than exposure through breast milk, this has
been debated (39,40). If these measurements
in breast milk had not been conducted, such
information about contributory effects on
health outcome would not have been recog-
nized. Nevertheless, because the significant
nutritional and immunologic benefits from
breast-feeding outweigh the limited adverse
health effects from the presence of environ-
mental chemicals in breast milk, the
American Academy of Pediatrics continues
to recommend breast-feeding in most cir-
cumstances (41). 
Concerns have been raised about the lev-
els of environmental chemicals in breast milk
and other human tissues and effects on the
mother. Women with a higher DDE con-
centration in their breast milk have a shorter
duration of lactation than do those with a
lower concentration (42,43). Another con-
cern is for the occurrence of breast cancer
with exposure to organochlorine chemicals
(e.g., DDE, DDT, PCBs). This association
has not been consistently demonstrated (44).
Analytes Monitored in Breast
Milk
Before describing the analytic considerations
for analyzing breast milk for environmental
chemicals, we need to list the analytes of
interest.
Organohalogens. The ﬁrst class of chemi-
cals generally discussed in breast milk moni-
toring programs is the organohalogens,
which include the organochlorine insecti-
cides, PCDDs, PCDFs, PCBs, PBBs, and
PBDEs. On the basis of analytic chemistry
methods, these chemicals are considered to
be semivolatile and are generally measured
by gas chromatographic methods after an
extraction process.
Volatile organic compounds. In the U.S.
EPA’s analyses of breast milk collected from
five U. S. cities, 26 halogenated hydrocar-
bons, 17 aldehydes, 20 ketones, 11 alcohols,
2 acids, 3 ethers, 1 epoxide, 14 furans, 26
other oxygenated compounds, 4 sulfur-con-
taining compounds, 7 nitrogen-containing
compounds, 13 alkanes, 12 alkenes, 7
alkynes, 11 cyclic hydrocarbons, and 15 aro-
matic compounds were found, including sig-
niﬁcant amounts of hexanal, limonene, and
dichlorobenzene (14). These chemicals are
generally measured by gas chromatographic
methods following a purging or headspace
sampling process.
Metals. Heavy metals, including lead,
mercury, and cadmium, are seldom moni-
tored in breast milk; one reason is that their
levels are only about 20% of their levels in
maternal blood. These metals can be present
either in their inorganic forms or as
organometallics. They are generally mea-
sured by atomic absorption spectroscopy
(AAS), inductively coupled argon plasma
spectroscopy, or mass spectrometry (MS),
often following a digestion process.
Other chemicals. As in most cases, the
“other chemical” category contains a variety
of chemicals ranging from contemporary
pesticides, polycyclic aromatic hydrocarbons,
nicotine, ethanol, phthalates, musk xylenes,
and phytoestrogens, such as genestein. These
chemicals are generally determined by either
gas chromatography (GC) or high perfor-
mance liquid chromatography methods
(HPLC).
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The major methodologic goals of analyzing
breast milk for environmental chemicals are
the same as for analyzing any other biological
sample or, for that matter, any environmen-
tal sample for those environmental chemicals.
The goals of the method are built around
speciﬁcity, sensitivity, robustness, ruggedness,
accuracy, precision, ability to measure multi-
ple analytes, and high throughput. However,
the analytic approach for analyzing milk for
environmental chemicals must take into
account the fat content of milk. This leads to
some general (e.g., specimen collection,
preparation) and specific (e.g., congeners)
considerations for measuring environmental
chemicals in breast milk.
Specimen Collection
The sample must be collected under a well-
designed protocol; this includes signed con-
sent forms and approval by an Office for
Human Research Protection-approved
Institutional Review Board. Key issues of
breast milk collection are the adherence to
the protocol, administration of a well-
designed questionnaire, accurate labeling of
all containers, avoidance of contamination,
and the adequacy of the specimen. The
breast and hands should be clean, yet soap
should be avoided as much as possible. The
use of creams or ointments on the nipples
should be used outside the sampling time for
the analysis, but if this is not possible
because of tenderness, the breasts should be
washed thoroughly and rinsed with copious
amounts of water before sampling. The milk
can be expressed either manually or by a
breast pump, but if a pump is used, it must
be free of contamination. Some groups rec-
ommend collecting the milk specimen from
one breast using an electric pump while the
baby feeds on the other breast in order to
take advantage of the let-down reflex. The
collecting bottle must be provided free of
contamination and should be washed, rinsed
with water, and rinsed with acetone before
being given to the mother. If the analysis
calls for inorganic elements, the collecting
bottle is generally acid rinsed. At least 50 mL
of milk should be collected in a wide-necked
glass bottle; if the milk is expressed manu-
ally, avoid contact between the breast and
the jar. In general, glass; Teﬂon; certain plas-
tics, such as polyethylene; and aluminum
foil (if only organic chemicals are measured)
are suitable to come in direct contact with
the specimen. Certain plastics, such as
polyvinyl chloride, and metal containers are
to be avoided because their constituents can
interfere with certain detectors interfaced
with the analytic instrument. Aluminum foil
(dull side down) or Teﬂon is generally used
as liner material for the lid. 
Specimen Storage and Transport
If the breast milk is collected several times
over a 72-hr period, then the milk in the
collection container should be stored in the
home freezer or in a home refrigerator.
Tablets of potassium dichromate, a preserva-
tive, may be added if necessary. If volatile
organic chemicals are not intended to be
measured, the milk specimen should be
warmed to 38°C and inverted several times
to mix the cream layer, and then divided
into aliquots into several bottles to minimize
the effects of freeze–thaw cycles. These bot-
tles should have labels that will remain intact
and readable throughout transport and stor-
age (45). The bottles containing the samples
should be placed in a thermoinsulated box
with dry ice; the bottles should not contact
each other or the dry ice. The laboratory
staff should be notified of the shipping of
the samples and given all information about
the shipping. When the samples arrive, the
laboratory staff should remove the bottles
from the shipping box; note the condition of
the labels, the bottles, and the milk; and
relay this information back to the shipper.
For the measurement of most analytes, the
samples can be stored indeﬁnitely at –70°C. 
General Analytic Approach
Several methods exist for measuring environ-
mental chemicals in breast milk. Of course,
as mentioned above, the specific method
depends on the analytes of interest; therefore,
speciﬁc methods are not practical to discuss
without listing the specific chemicals or at
least classes of chemicals. We classify the
environmental chemicals as either inorganic
chemicals (including organometallic com-
pounds) or organic compounds, which are
further divided into volatile or semivolatile
classes. The measurement process of the
chemicals of concern consists of four primary
steps: lipid determination; sample prepara-
tion; instrumental analysis, which usually
involves a chromatographic step; and data
analysis and evaluation. Before the measure-
ment process, the samples to be analyzed in
an analytic run or batch should be removed
from the freezer, checked for proper labeling,
brought to 38°C (unless they are to be ana-
lyzed for volatile chemicals), and mixed by
gentle inversion. The number of samples that
can be analyzed by an analyst or a team of
analysts in 1 day generally determines the
number of samples included in an analytic
run. Into this batch are added quality control
samples that consist of milk that has been
fortified with the analytes and/or milk that
has not been fortified, as well as a solvent
blank, which is often purified water that is
analyzed in the same manner as the milk
samples. The quality control samples can
consist of bench or internal quality control
samples and external or blind quality control
samples. Generally, both of these samples are
prepared in a bulk manner and then the milk
is transferred by pipette to the container so
that the quality control samples are identical
in appearance to the unknown samples. In
our study, both the bench and the blind
quality control samples have been analyzed
by the laboratory numerous times, and the
mean values and control limits have been
determined for the analyses. Laboratory per-
sonnel know the positions of the bench qual-
ity control sample and of course the quality
of the blank in the analytic run, but they do
not know the position of the blind quality
control sample. We also recommend analysis
of standard or certiﬁed reference materials, if
they are available, for the particular analytes
in breast milk. 
Sample Preparation and Lipid
Determination
Semivolatile organic compounds. The pur-
poses of the sample preparation step and
lipid determination step are to extract the fat
components and the analytes of interest from
the remainder of the milk sample, to deter-
mine the fat content of the milk sample, and
to further prepare the extract for instrumen-
tal analysis. The lipid content may be mea-
sured in the entire amount of sample or in an
aliquot of the milk specimen. In either case,
the homogenized milk sample is treated with
a denaturing agent such as ethanol, sodium
oxalate, or formic acid, and the lipids are
extracted into an organic solvent. The extract
is sometimes passed through a column con-
taining a drying agent such as sodium sulfate
to remove traces of water. The solvent is con-
centrated to dryness and the lipid weight is
determined gravimetrically. The percentage
of the lipid content of the specimen is deter-
mined especially when lipophilic compounds
such as PCBs and organochlorine insecticides
are measured because, most frequently, the
concentrations of the analytes of interest are
reported on a lipid-adjusted basis as well as
on a whole-weight basis. The lipid-adjusted
basis normalizes the concentrations of the
lipophilic environmental chemicals to the
different lipid contents of the milk, both
within a mother and among mothers. The
lipid-adjusted concentrations of lipophilic
compounds are used for population estimates
of these chemicals in the mothers and for
defining infant intake of these chemicals.
These chemicals must be accurately and pre-
cisely measured on a whole-weight basis to
adjust their concentrations to a lipid basis.
This lipid determination step, however, is
critical, and because of the potential for
incomplete extraction, incomplete concentra-
tion of the sample, and weighing errors, the
overall error is often more associated with the
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measurement of the analytes. This was
demonstrated in the first WHO-sponsored
interlaboratory study for measuring PCBs,
PCDFs, and PCDDs in breast milk (46). In
addition to the liquid/liquid extraction
method, milk samples have also been pre-
pared for further analysis by using lyophiliza-
tion or freeze drying of the milk. 
The goal of the sample preparation step is
to prepare the sample for instrumental analy-
sis while maintaining the high recovery of the
analytes but separating them from the lipids
and from other coextracted potential interfer-
ants. The method used for the sample prepa-
ration step (sometimes called the “cleanup
step”) is determined by the physical and
chemical nature of the analytes and instru-
mentation available to the laboratory. This
concept sounds straightforward but can often
tax the ability of analytic chemists. For exam-
ple, as we mentioned, human milk is gener-
ally 3–4% lipids, but the analytes of interest,
such as PCDD and PCDF congeners, PCB
congeners, and organochlorine insecticides,
are generally present at parts-per-quadrillion,
parts-per-billion, and parts-per-billion con-
centration levels, respectively. Thus, the
method needs to extract the lipids and the
analytes and separate all of these components
from other components of the milk sample
with high efﬁciency and speciﬁcity. To carry
this one step further, the PCDDs, PCDFs,
and coplanar PCBs must also be separated
from the “regular” PCBs and organochlorine
insecticides before instrumental analysis. The
specificity, sensitivity, precision, accuracy,
“ruggedness,” and robustness of the analytic
method are highly related to the ability of
this step to meet its goal. 
Some methods used for cleanup for the
measurement of semivolatile analytes include
column chromatography, thin-layer chro-
matography, sweep codistillation, and gel
permeation chromatography. More recently,
chromatographic techniques such as solid
phase extraction (SPE) have been used in the
cleanup of many semivolatile chemicals,
including pesticides and organochlorine
compounds. A variety of sorbents are com-
mercially available for solid phase extraction
(SPE). These sorbents can be used in combi-
nation with the speciﬁc properties of the ana-
lytes to selectively isolate the compounds of
interest from other components of the sam-
ple. SPE can be used in two different modes:
the ﬁrst is to initially retain the analytes on
the column packing, thereby allowing poten-
tial interferants to pass through the column,
and then elute the analytes with the pre-
scribed eluent; the second is to retain the
interfering substances, thereby allowing the
analytes to pass initially through the column.
If the second mode is used, typically an
additional preparation step is employed to
isolate the components from the matrix.
Another technique, which has the potential
for extracting lipophilic compounds directly
from milk, is stir bar sorptive extraction.
Volatile organic compounds. To analyze
breast milk for volatile analytes, the sample
preparation step is based on volatization of
the analyte, which can include a process
based on volatilization of the analyte into the
headspace above the sample or by a similar
process followed by a purge of the headspace
by an inert gas, then trapping of the analytes
onto an adsorbent. The adsorbent is
reheated and the analytes are released as part
of the instrumental analysis process. A sepa-
rate aliquot of the milk sample is generally
used for lipid determination.
Inorganic chemicals. To analyze breast
milk for metals, the sample preparation step
is generally based on a digestion of the pro-
teins in the milk, thereby releasing the metal
to be measured by an instrumental analysis
process. Lipid content may or may not be
determined because the metals are generally
not partitioned into the lipids.
Instrumental Analysis and
Quantiﬁcation
Once the specimen has been prepared for
instrumental analysis, the analytes of interest
can be further separated from each other and
from remaining potential interferants by
high-resolution chromatographic techniques
such as capillary column GC or HPLC. The
method is selected depending on the physical
and chemical properties of the chemical (e.g.,
volatility, thermal stability). Following sepa-
ration, the analytes are detected using a vari-
ety of analytic instruments, including mass
spectrometers, although historically halo-
genated, semivolatile organic compounds
have been detected by electron capture detec-
tors. Once detected, these particular com-
pounds are quantified by two primary
methods, the external standard method and
the internal standard method. The external
standard method is generally the less accurate
of these two quantitative techniques. It relies
on a standard curve consisting of the detector
responses of the analyte (y-axis) versus the
varying concentrations of the analyte in stan-
dard solutions (x-axis) and generally makes
no amends for losses of the analyte during
the analysis of each unknown; however,
recovery losses can be estimated by using one
of two approaches. The first approach is to
incorporate a surrogate compound in the
milk sample and monitor its recovery
throughout the analytic process; for example,
the analyst may add a PCB congener that is
generally not detected in human milk to the
milk sample and monitor its recovery. The
recovery of the analytes of interest can be
inferred from the recovery of the added PCB,
although no adjustments for losses are made
when reporting the concentration levels of
the analytes. The second approach is to spike
a milk pool with known amounts of the ana-
lytes of interest, analyze the milk pool many
times, and calculate and average the recovery
of the analytes over time. The analyst then
assumes that during the analyses of the actual
samples, the analytes are recovered to a simi-
lar degree, but again the analyst does not take
this into account during the reporting of the
concentration levels of the analytes. 
The internal standard method involves
the addition of one or more compounds (the
internal standards) that ideally are recovered
to the same degree (but at least to a consistent
relative degree) as the analytes during the ana-
lytic method; this relative behavior is deter-
mined by previous analyses of milk pools
spiked with the analytes and the internal stan-
dards. The internal standards should be added
and equilibrated into the sample before the
extraction step. Therefore, any losses of the
analytes during the analytic method are
accompanied by similar losses (or at least
deﬁned losses) of the internal standards. The
quantitative result for a given analyte in a
milk sample is calculated from a standard
curve consisting of the ratio of the detector
responses of varying concentrations of that
analyte divided by the detector responses for a
constant concentration of its internal standard
(y-axis) versus the varying concentrations of
the analyte in standard solutions (x-axis). 
The isotope dilution MS technique for
quantification is essentially the same as the
internal standard quantiﬁcation method with
two exceptions. The ﬁrst exception is that the
internal standard is actually the same chemical
(differing only in isotopes) as the analyte;
therefore, the stable isotopically labeled inter-
nal standard should chemically and physically
mimic the analyte, and any loss of the analyte
during the analytic process should be accom-
panied by a similar loss of its internal stan-
dard. Its use allows for a complete accounting
of any loss of analyte and thus “adjusts” the
recovery to 100%; therefore, as with the inter-
nal standard method, no recovery calculations
have to be made. The concentration level of
the analyte is calculated in a similar manner as
described for the internal standard method.
The second exception is that because the ana-
lyte and internal standard are the same chemi-
cal (differing only in isotopes), their primary
difference is only in mass, which means that
the instrumental detector must be able to dis-
tinguish the analyte from the internal stan-
dard on the basis of mass (i.e., a mass
spectrometer must be used). For increased
sensitivity that is often required in milk analy-
sis, the mass spectrometer generally monitors
only selected ions. The use of the isotope
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combination of speciﬁcity and sensitivity of
mass spectrometry, especially when used in
the selective ion monitoring mode, can pro-
vide the basis for “deﬁnitive” methods in ana-
lytic chemistry. The only pertinent weakness,
besides the expense of instrumentation and
the labeled standards, is the inability to quali-
tatively distinguish among certain isomers
that have similar chromatographic properties
and mass spectral fragmentation patterns (i.e.,
structural isomers that coelute); in such cases,
Fourier-transform infrared spectroscopy can
be used, even though it does not have the
same inherent sensitivity as MS in the selected
ion monitoring mode. However, with the
advent of many more widely varying chro-
matographic columns, including those based
on chirality, this weakness is seldom relevant.
From a quantitative viewpoint, the major
sources of error in IDMS are in the purity of
the native (unlabeled) standards and some-
times the labeled standard, and the inaccurate
addition of the prescribed amount of the solu-
tion containing the labeled standard. A fourth
method of quantiﬁcation, the spiked addition
method, is seldom used because repeated
analyses are required for each sample. The
ﬁrst analysis involves the analysis of the sam-
ple without the addition of any native stan-
dard to the sample, but each successive
analysis involves the addition of increasing
amounts of labeled standard. A calibration
plot is constructed from the areas of the
spiked samples, and the x-intercept is repre-
sentative of the concentration of the analyte
in the milk sample. 
The mass spectrometers used for measur-
ing environmental chemicals in milk can
range in price from the relatively inexpensive
mass selective detectors (around $100,000
U.S.) to tandem mass spectrometers (around
$300,000 U.S.) to high-resolution mass spec-
trometers with various designs and conﬁgura-
tions (range from $500,000 to $1,000,000
U.S.). With proper laboratory technique, the
use of pure standards, and IDMS, the instru-
mental analysis step seldom leads to impre-
cise and/or inaccurate measurements.
Data Analysis and Evaluation
Most laboratories use computers to better
track the status of samples from their delivery
into the laboratory to reporting of the data, to
control the instruments for analyzing the sam-
ple, and to calculate the results. This generally
results in fewer laboratory errors. Nonetheless,
laboratory personnel must be aware of the
potential for errors, must properly set up each
of the computers, and must check the output
of each step. They should help determine
which data output parameters are necessary
and their specifications for determining the
quality of the data and for determining
whether the results for an individual sample
and/or for the entire analytic run are “in con-
trol.” The determination of whether the
entire analytic run is in control is based, to a
large degree, on the results of the quality con-
trol samples. These quality control samples
also evaluate the performance of the analytic
method in a given laboratory over time. The
determination of whether the results for a
particular milk sample are in control is gener-
ally based on other factors relevant to the
type of analyses. For example, for GC/MS
methods, these quality control factors may
include the retention times of the analytes
and the internal standard; the degree of reso-
lution of the analyte from other analytes or
contaminants; the percent recovery of the
internal standard; and, particularly if halo-
genated (chlorinated or brominated) com-
pounds are being measured, the ion ratios of
the halogen atoms (e.g., if the analyte con-
tains one chlorine, the contribution of 37Cl
should be about one-third that of 35Cl). If
compounds not containing halogen atoms
are being measured, certain ion(s) can be
used for quantiﬁcation and another for con-
ﬁrmation in much the same manner. 
Of particular concern in trace analysis is
how to report and statistically treat concentra-
tion levels that are below the limit of detec-
tion (LOD). The LOD is defined by the
lowest concentration of chemical that the ana-
lytic method can measure. It is determined by
the measured value that differs in a statisti-
cally signiﬁcant manner from having “zero”
chemical in the specimen (47). The efﬁciency
of the analytic method in preparing extracts
free of potential interferants (but still recover-
ing a high percentage of the analytes of inter-
est) and the sensitivity of the instrumental
system affect the LOD for the method. The
LOD should be determined in each labora-
tory for each instrument (instrumental LOD)
and for each method (method LOD); fre-
quently, the method LOD is calculated for
each and every sample analysis. When mea-
surements are calculated to be < LOD, the
concentrations are generally reported as “non-
detectable” with the LOD given. However,
for parametric statistics, a number must be
assigned for each sample. To circumvent this
problem, values ranging from the most “con-
servative” value of zero to one-half of the
detection limit concentration, to the detec-
tion limit divided by √
—
2, to the most “liberal”
value—the detection limit itself (48)—have
been used. More sophisticated modeling
methods have also been used to estimate the
concentration levels for nondetectable results
(49). From a laboratory perspective, our gen-
eral policy is to statistically use all values
determined by MS that are at or above
the LOD and that pass the quality control cri-
teria (for the run; for the sample; and if the
analysis is for multiple analytes, then also for
individual analytes within the sample).
However, what about reporting concentra-
tions when they are below the LOD? Two
scenarios exist: For the ﬁrst, all of the quality
control criteria are again met except that the
calculated concentration value is below the
LOD; in this case, we report the calculated
value with the caveat that the result is below
the LOD—for statistical purposes in our epi-
demiologic studies, we believe that this is the
most accurate value to use for that sample.
For the second scenario, the quality control
criteria for the analytic run are met but no sig-
nal for a particular analyte is discernible; those
results are reported as below the LOD, and
no number above zero can be assigned to
them. Other researchers treat both scenarios
as the same and report all results below the
LOD as nondetectable and then assign, for
statistical purposes, a number as described
above (e.g., one-half the LOD). Because our
analytic methods have become much more
sensitive, concentrations of targeted chemicals
in the breast milk from exposed populations,
as well as from the general population, are sel-
dom calculated as being below the LOD;
however, we are still faced with this problem.
As shown by many researchers, our exposure
to many environmental chemicals is decreas-
ing (fortunately), and their milk concentra-
tion levels may not continue to be sufﬁcient
for detectable measurements. Another sce-
nario that can lead to nondetectable results is
that we often measure multiple analytes in an
analytic run, and the more analytes that we
measure in an analytic run, the lower the sen-
sitivity for the measurement process of all of
the analytes, either because of instrumental
reasons or for recovery reasons. Therefore, the
use of multianalyte methods has many advan-
tages, but generally they have higher LODs
than single analyte methods. 
One approach to help ensure the avail-
ability of an adequate volume of milk for
measuring low levels of environmental chem-
icals is to combine individual samples of sim-
ilar demographic or presumed-exposure
characteristics into a single sample to prepare
a “pooled sample.” This practice is widely
used to decrease the number of samples to be
analyzed and consequently it allows for a
larger number of mothers to be represented
in the survey; in addition, it saves laboratory
resources. Another beneﬁt of pooling speci-
mens is the use of small volume specimens
that would otherwise be excluded from
analysis. However, some issues should be
considered when specimens are pooled: the
loss of direct association with the donors; the
inability to perform statistical analysis
between pooled populations because of the
loss of variability within the pooled popula-
tion; the reporting of estimated instead of
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population; and the disproportionate weight-
ing of the measurements because of dilution.
The creation of subgroups within each pool
can establish a variance for the pool to allow
for comparison between pools. Additional
consideration needs to be given for the vari-
ability in lipid content relative to time of
breast-feeding among the donors before the
specimens are pooled. Therefore, whether the
volume of each sample to be pooled should
be based on a given volume per sample or a
given amount of lipids per sample becomes
questionable. Although the latter method
may be preferred, it is seldom used because it
requires the additional measurement of the
lipid content of the samples before pooling. 
Analytic Issues with Speciﬁc
Chemicals
PCDDs, PCDFs, and certain PCBs. The
PCDDs, PCDFs, and certain PCB congeners
represent classes of many compounds that
exhibit similar mechanisms of toxic actions.
There are 75 congeners of PCDDs, 135 con-
geners of PCDFs, and 209 PCB congeners.
All of these congeners could potentially be
dispersed into the environment. However,
not all of the congeners bioaccumulate in the
food chain and hence are not found in the
fatty stores in humans. For example, we gen-
erally consider that only 7 of the PCDDs and
10 of the PCDFs are stored in the fatty tis-
sues of the human body. That is the good
news. The bad news is that these 17 are the
most toxic members of these two classes of
chemicals. The most toxic congeners have
four or more chlorine atoms substituted (for
hydrogen) on the aromatic rings, and all four
of the lateral positions (the 2, 3, 7, and 8
positions) must be substituted with a chlo-
rine atom. Because of their dioxin-like activ-
ity, 12 PCBs are generally reported along
with the PCDDs and PCDFs; 4 of these
PCBs (the coplanar PCBs or non-ortho-sub-
stituted PCBs) have no chlorine substitution
in either of the four ortho-positions (the 2,
2´, 6, or 6´-positions) and 8 of these PCBs
(the mono-ortho-substituted PCBs) have only
one of these four positions substituted with a
chlorine. Therefore, approximately 30 differ-
ent chemicals are reported as dioxin-like
chemicals in humans. Because so many con-
geners need to be monitored for dioxin-like
activity, methods to facilitate the interpreta-
tion and reporting of the data (as well as to
establish regulatory limits) were adopted. In
short, the reported value for dioxin-like
chemicals is frequently condensed to one
value—the toxic equivalency (50). 
The toxic equivalency is a weighting fac-
tor derived by multiplying the concentration
of each of approximately 30 individual
dioxin-like chemicals by their respective
toxic equivalency factor and then summing
these values. The toxic equivalency factor is a
relative factor based on ability of each chem-
ical (relative to the most toxic congener,
TCDD) to induce cytochrome P450 1A1
and its afﬁnity for the aryl hydrocarbon (Ah)
receptor. The toxic equivalency approach
allows for a meaningful comparison of the
toxicologic contribution of each dioxin-like
compound and a comparison of the concen-
tration of each of these compounds within a
biological or environmental sample and
between samples. Some of the limitations to
this approach include the nonadditive antag-
onistic effect of various chemical mixtures
(51) and mechanisms of toxicity not appreci-
ated by either the Ah receptor or cytochrome
P450 activity (52). 
Another approach that has been devel-
oped recently for measuring dioxin-like total
equivalents is the chemical-activated luciferase
gene expression (CALUX) bioassay (53). This
method, based on the Ah receptor agonistic
activity of these chemicals, is less expensive
and has higher throughput than methods
based on GC/MS. However, the method still
requires an extraction, lipid determination,
and cleanup of the milk sample. Furthermore,
the ﬁnal result is only a toxic equivalent and
thus gives no information about the dioxin
pattern of exposure, which yields information
about the exposure scenario, including the
source. Also, frequently this method overesti-
mates the concentration of PCDDs, PCDFs,
and dioxin-like PCBs because other compo-
nents in the breast milk may possess Ah ago-
nistic activity. Nonetheless, this method is
suitable for screening of samples to estimate
dioxin levels and for prioritizing those sam-
ples for dioxin analysis by GC/MS.
Another area of interest in measuring
chemical classes with many congeners, such
as PCBs, is the interpretation of residue data.
The toxic mechanism of action for most of
the PCB congeners is different from that of
dioxins; in fact, the 209 PCB congeners can
act through a variety of toxic mechanisms.
So, from a toxicologic standpoint it is impor-
tant to be able to separate and quantify each
of the congeners that appear in breast milk.
Of course, not all of the congeners are pre-
sent in any specimen, environmental or bio-
logical; the number of congeners identified
depends not only on the exposure scenario
but also on the analytic method. Over the
years, as technology and methods have
improved, so has the ability to chromato-
graphically resolve more compounds and to
measure them with improved sensitivity.
Thus, PCBs are now frequently reported as
individual congeners, although the individual
congeners themselves are frequently summed
to give total PCBs; this is done to allow for
direct comparison with historical data and
for ease of correlation with health end points,
although this approach may be flawed for
both uses. Historically, total PCBs were cal-
culated from comparison to the commercial
material that chromatographically was most
similar to the chromatographic pattern of the
extract from the biological sample; however,
little or no information was available for indi-
vidual congeners. Methods were developed
for calculating total PCBs from these chro-
matograms. However, these methods of
interpretation led to an over estimation of
the actual measurement of the chemical class
compared with analytic methods that can
resolve all the congeners (54). Thus, the
comparison of data among laboratories with
different abilities to resolve many congeners
can be problematic. Data sets can be best
compared from laboratories that can identify
and quantify a similar number of congeners
using similar techniques. 
Heavy metals. Heavy metals appear in
milk at smaller concentrations than the lipid-
soluble chemicals and are about 20% of the
level found in blood from the same person.
This is attributed to their low lipid solubility
and high binding to erythrocytes. The
amount of heavy metal exposure to the infant
from breast milk appears to be low in com-
parison with other sources; further informa-
tion is needed about the pharmacokinetics of
the heavy metals (especially lead) as they go
from mother to infant. An area of concern
regarding the analysis of heavy metals is the
identiﬁcation of the various species of metals
(especially for mercury and arsenic). This is
important because different species of metals
have varying toxic effects. For example,
methylmercury, which binds to sulfhydryl
groups, is a central nervous system toxicant
and inorganic mercury is a nephrotoxicant.
Thus, the need to be able to measure individ-
ual species of the heavy metals becomes
apparent. AAS is commonly used to detect
heavy metals, which can be speciated by using
selective specimen preparation methods. The
LOD with AAS can be decreased with ﬂame-
less (e.g., electrothermal) atomizers. 
Future Trends
The assessment of exposure to environmen-
tal chemicals in breast milk from the general
population needs to pursue the measure-
ment of environmental chemicals that have
not been well characterized and have poten-
tial adverse health effects (e.g., pesticides,
such as organophosphates; xenoestrogens;
brominated aromatic hydrocarbons; sol-
vents; and polycyclic aromatic hydrocar-
bons). In addition, breast milk monitoring
needs to be increased in populations that
may be unduly exposed to certain chemicals
that are easily measured in breast milk. As
mentioned previously, breast milk is a
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also a human food, and although the expo-
sure lasts for a relatively short and limited
time, the amount of chemical intake on a
daily basis may far exceed the public health
criteria, which are generally based on an
exposure period of 70 years. Public health
ofﬁcials need to recognize this. In addition,
chemists need to measure these chemicals in
an accurate and precise manner. Therefore,
the chemist must be kept abreast of labora-
tory criteria in order to help ensure the qual-
ity of the data. An increasing number of
laboratories will have to demonstrate quality
through such programs as the Clinical
Laboratory Improvement Amendment of
1988 (55) and interlaboratory studies. The
chemists are responsible for providing accu-
rate and precise analytic data for assessing
exposure so that the relationship between
exposure and adverse health outcomes can
be made most accurately; this in turn should
lead to improvements in legislation and reg-
ulation that protect people but not to an
unwarranted degree.
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